A best evidence topic in cardiovascular surgery was written according to a structured protocol. The question addressed was whether administering sodium bicarbonate (NaHCO 3 ) prevents contrast-induced nephropathy (CIN) in cardiovascular patients undergoing contrast imaging. In total, 266 papers were found using the reported search, 16 of which represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. CIN is thought to occur as a result of ischaemic or oxidative injury to the kidney. It is postulated that NaHCO 3 attenuates this renal damage by alkanizing renal tubular fluid thus reducing the generation of contrast-induced free radicals, which damage the kidney. Of the 16 trials, 15 recruited patients with various degrees of renal dysfunction at baseline. The benefit of using NaHCO 3 was demonstrated at all stages of chronic kidney disease. Apart from four studies, 12 studies used low toxicity, low-osmolar contrast. Merten et al. published the first trial of NaHCO 3 vs (saline) NaCl in preventing CIN, demonstrated a significantly lower rate in the NaHCO 3 group and advocated its widespread use. Subsequent trials using the same regimen have collaborated these results. However, more recently, Gomes et al. concluded that NaHCO 3 is not superior to saline-based hydration. Similarly, Brar et al. randomized 323 patients with moderate-to-severe renal insufficiency to receive either an NaHCO 3 or an NaCl infusion and observed no difference in CIN rates. Two studies investigated the effects of rapid urine alkanization with bolus injections of NaHCO 3 prior to contrast and found significant reductions in CIN rates compared with NaCl-treated groups. One study observed that NaCl is superior to NaHCO 3 , while all other studies showed a beneficial effect or no difference between NaCl-and NaHCO 3 -based hydration. The most recent meta-analysis by Jang et al. incorporated 3609 patients across 19 trials and concluded that NaHCO 3 -based hydration regimens are superior to NaCl-based ones. Based on this review, the authors recommend NaHCO 3 alongside an NaCl hydration regimen. The exact regimen will depend on the context within which contrast is being administered and needs further evaluation.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION
In [cardiovascular patients undergoing contrast-enhanced diagnostic/interventional imaging], will [sodium bicarbonate] prevent [contrast-induced nephropathy]?
CLINICAL SCENARIO
A 67-year old lady with underlying renal insufficiency undergoes an emergency coronary angiography (CAG). Three days later, she develops acute-on-chronic renal failure with pulmonary oedema, secondary to the contrast, requiring temporary dialysis. Could this complication have been prevented with sodium bicarbonate (NaHCO 3 )? You resolve to study the literature.
SEARCH STRATEGY

Medline 1950 to February 2013 using OVID interface [(nephropathy) OR (failure) OR (injury)] AND (bicarbonate) AND (contrast) AND [(kidney) OR (renal)].
SEARCH OUTCOME
In total, 266 papers were found using the reported search. From these, 16 relevant papers are presented in Table 1 . Only published papers that contained a head-to-head comparison of NaHCO 3 vs sodium chloride (NaCl)/placebo were included. Studies that combined other preventive strategies were excluded. Single-centre, single-blinded, RCT (level 2)
n T = 119
Renal insufficiency Yes
Mean baseline eGFR 43 ml/min/1.73 m 2 
Procedure
Diagnostic or interventional Cardiac or peripheral procedures
Contrast media Non-onic, low-osmolar (Iopamidol)
Hydration regimen 3 ml/kg/h for 1 h before and 1 ml/kg/h for 6 h after the procedure of NaHCO 3 (n = 69) or NaCl (n = 68) 
Renal insufficiency Yes
Mean baseline sCr
mg/dl
Procedure Elective CAG or PCI
Contrast media
Ionic, low-osmolar (Ioxaglate)
Hydration regimen 1 ml/kg/h for 6 h before and after: NaHCO 3 (n = 88) NaCl (n = 88)
Incidence of CIN (increase in sCr of >25% or 0.5 mg/dl within 3 days)
Lower incidence of CIN with NaHCO 3 compared with NaCl alone (4.5 vs 13.6%, P = 0.036)
Conclusion: NaHCO 3 better
Limitations: (i) Underpowered study for the incidence of CIN (ii) Limited follow-up Masuda et al. (2008) , Circ J, Japan [4] Single-centre, open-label RCT (level 2)
Renal insufficiency Yes
mg/dl
Procedure Emergency CAG or PCI
Contrast media
Non-ionic, low-osmolar (Iopamidol)
Hydration regimen 3 ml/kg/h for 1 h before and 1 ml/kg/h for 6 h after the procedure of NaHCO 3 (n = 30) or NaCl (n = 29) Single-centre, double-blinded RCT (level 2)
Renal insufficiency Yes
Mean baseline sCr 1.5 mg/dl Procedure Elective CAG or PCI
Contrast media
Non-ionic, iso-isomolar (Iodixanol)
Hydration regimen 2 ml/kg/h for 2 h before and 1 ml/kg/h for 6 h after the procedure of NaHCO 3 (n = 71) or NaCl (n = 74)
Incidence of CIN (increase in sCr of >25% or 0.5 mg/dl within 2 days)
Similar CIN rates in both groups (4.2 vs 2.7%, P = 0.614)
Conclusion:
No difference, recommended low-toxicity contrast with any hydration regimen
Limitations: (i) Underpowered study to show a significant difference in CIN incidence
Single-centre, double-blinded RCT (level 2)
Renal insufficiency No
Mean baseline eGFR 72 ml/min/1.73 m 2 Procedure CAG or PCI
Contrast media
Hydration regimen NaHCO 3 3 ml/kg/h 1 h before and 1 ml/kg/h 6 h after (n = 96) NaCl 1 ml/kg/h 6 h before and after (n = 96)
Incidence of CIN (increase in sCr of >0.5 mg/dl or decrease in eGFR of >25% within 2 days)
Risk if CIN higher in the NaCl group (P ≤ 0.04) group, but not in the NaHCO 3 group
Conclusion:
NaHCO 3 Single-centre, double-blinded RCT (level 2)
Renal insufficiency Yes
Mean baseline eGFR 45 ml/min/1.73 m 2
Procedure
Incidence of CIN (increase in sCr of >25% or ≥0.5 mg/dl within 5 days)
Similar incidence of CIN in both groups (7.4 vs 5.9%, OR 1.26, 95% CI 0.45-3.5, P = 0.6)
Conclusion:
No difference, hydration with NaCl is as effective in patients with mild renal disease
Limitations: (i) Wide confidence intervals for the development of CIN due to small sample size Hydration regimen 3 ml/kg/h for 1 h before and 1 ml/kg/h for 6 h after the procedure of 75 ml of 8.4% NaHCO 3 to 1 l of 0.45% NaCl (n = 36) 1075 ml of 0.45% sodium chloride (n = 36)
Incidence of CIN (increase in sCr of >25% or >0.5 mg/dl within 5 days)
Incidence was similar in both groups (6.1 vs 6.3%, OR = 0.97, 95% CI 0.13-7.3, P = 0.1)
Conclusion: No difference
Limitations: (i) 11 (15%) deviation from protocol due to mistaken baseline renal function or unstable sCr (ii) Small sample size Castini et al. (2010) , Clin Cardiol, Italy [11] n T = 103
Renal insufficiency Yes
Incidence of CIN (defined as sCr of ≥25% over the baseline within 5 days)
Incidence of CIN was similar in both groups (14%)
Conclusion: No difference
Limitations:
Continued Hydration regimen IV bolus injection of 0.5 mg/ml 154 mEq/l NaHCO 3 (n = 30) IV bolus injection of 0.5 mg/ml NaCl (n = 29) Both groups also received NaHCO 3 at 1 ml/kg/h during and for 6 h after
Incidence of CIN (increase in sCr of >25% or ≥0.5 mg/dl within 2 days)
Incidence of CIN was higher in the NaHCO 3 group compared with the NaCl group (3.3 vs 27.6%, P = 0.01)
Conclusion:
NaHCO 3 better, rapid alkanization by bolus injection of NaHCO 3 is effective in emergency procedures
Limitations: (i) Small sample (ii) Study terminated early due to concerns in the NaCl group of not giving NaHCO 3 Motohiro et al. (2011), Am J Cardiol, Japan [13] Multicentre, open-label RCT (level 2)
Renal insufficiency Yes
Mean baseline eGFR 44 ml/min/1.73 m 2
Procedure
CAG or PCI
Contrast media
Hydration regimen 1 ml/kg/h NaCl 12 h before, change to NaHCO 3 1 ml/kg/h from 3 h preprocedure to 6 h post-procedure, then 1 ml/kg/h NaCl until 12 h post-procedure (n = 79)
More CIN in the NaCl only group (2.6 vs 13%, P = 0.012)
Conclusion:
NaHCo 3 better, total volume in each regime was the same, suggesting that alkanization of renal tubular fluid is as important as volume expansion
Limitations:
(i) Small sample size 
Continued
Contrast media
Non-ionic, low-osmolar Hydration regimen NaCl 1 ml/kg 12 h before and 12 h after procedure (n = 89) NaHCO 3 3 ml/kg 1 h before and 1 ml/kg/h 6 h after procedure (n = 87) NaHCO 3 20 min IV bolus and oral NaHCO 3 for 48 h (n = 82)
Incidence of CIN (increase in sCr of ≥25% or ≥44 μmol within 48 h) IV NaHCO 3 group suffered a lower incidence of CIN than the NaCl group (1 vs 9%, P = 0.02).
Similar CIN rates between the long-term IV NaHCO 3 and the short-term PO NaHCO 3 group
Conclusion: NaCl better 
RESULTS
The majority of studies involved subjects with underlying renal dysfunction undergoing CAG, using low-osmolar contrast. The definition of contrast-induced nephropathy (CIN) and hydration regimens varied among trials.
Merten et al. [2] published the first trial in which 119 patients with mild-to-moderate renal insufficiency were randomized to receive either NaHCO 3 or NaCl for 1 h before and 6 h after contrast. CIN rates were lower in the NaHCO 3 group (13.6 vs 1.7%, P = 0.02). The authors concluded that NaHCO 3 is a better prophylactic agent against CIN.
Ozcan et al. [3] randomized 178 patients with mild renal insufficiency to either NaHCO 3 or NaCl infused for 6 h before and after contrast and found a significantly lower rate of CIN in the NaHCO 3 group (13.6 vs 4.5%, P = 0.036), concluding that NaHCO 3 is a better hydration agent in patients with a moderate nephropathy risk.
Masuda et al. [4] randomized 59 patients with mild renal insufficiency to the Merten et al. protocol and showed a significantly lower rate of CIN in the NaHCO 3 group (7 vs 35%, P = 0.01). The authors concluded that NaHCO 3 hydration reduces the risk of CIN following emergency coronary procedures.
Brar et al. [5] randomized 323 patients with moderate-to-severe renal insufficiency to either an NaHCO 3 or an NaCl infusion for 1 h before and 4 h after contrast. The authors concluded that NaHCO 3 is not superior to NaCl in preventing CIN (13 vs 14.6%, P = 0.82).
Adolph et al. [6] analysed 145 patients with renal insufficiency and observed no difference in CIN rates (4.2 vs 2.7%, P = 0.614) between NaHCO 3 and NaCl infused for 2 h before and 6 h after contrast. They concluded that when using a low-toxicity contrast media, the type of hydration is irrelevant.
Pakfetrat et al. [7] investigated 192 patients with normal renal function using the Merten et al. protocol. They found the risk of CIN to be lower in the NaHCO 3 group (P ≤ 0.04). Contrast media Non-ionic, low-osmolar (n S = 15) Non-ionic dimeric iso-osmolar (n S = 2)
Ionic, low-osmolar (n S = 2)
Hydration regimen NaHCO 3 : 3 ml/kg/h 1 h before and 1 ml/kg/h 6 h after procedure (n = 14 studies) Controls: NaCl ± NAC at varying rates and duration Multicentre, open-label RCT (level 2)
Renal insufficiency Yes
Mean baseline eGFR 51 ml/min/1.73 m 2
Procedure
Elective CAG or PCI
Contrast media
Hydration regimen 3 ml/kg/h for 1 h before and ml/ kg/h and 6 h after the procedure of NaHCo 3 (n = 150) or NaCl (n = 151)
Incidence of CIN (increase in sCr of ≥0.5 mg/dl within 48 h) Similar in both groups (6.1% vs 6.0, P = 0.97)
Conclusion: No difference
Limitations: (i) sCr measured at 48 h; therefore, further rises may have been missed (ii) Only ionic low osmolality contrast media used, so results cannot be generalized to other types of contrast (iii) Limited follow-up
All comparisons presented as NaHCO 3 vs NaCl. n T : total number of patients in both groups; n S : total number of studies; CIN: contrast-induced nephropathy; sCr: serum creatinine; eGFR: estimated glomerular filtration (calculated using the Modification of Diet in Renal Disease study equation); CAG: coronary angiography; PCI: percutaneous coronary intervention; RCT: randomized controlled trial; 95% CI: confidence interval; OR: odds ratio; STEMI: ST-elevation myocardial infarction; CT: contrast tomography; HT: hypertension; HF: heart failure.
Vasheghani-Farahani et al. [8] compared a combined NaHCO 3 and NaCl regimen with an NaCl-alone regimen, with both groups receiving equal volumes. They randomized 265 patients with mild-to-moderate renal insufficiency and observed no difference in CIN rates between the two regimen (7.4 vs 5.9%, P = 0.6).
Tamura et al. [9] studied 144 patients with mild renal insufficiency and investigated the effect of a bolus injection of 20 mEq NaHCO 3 5 min before contrast together with a 12-h pre-and post-procedure NaCl hydration. The authors demonstrated a reduction in CIN rates in the NaHCO 3 group (12.5 vs 1.4%, P = 0.017), highlighting the beneficial effect of urine alkalinization.
Vasheghani-Farahani et al. [10] randomized 72 patients, with renal insufficiency and high risk of volume overload, to either NaHCO 3 in combination with half-saline or half-saline alone (given 1 h before and 6 h after contrast) and found similar CIN rates (6.1 vs 6.3%, P = 0.1) between the two regimens.
Castini et al. [11] used the Merten et al. protocol, randomizing 103 patients with mild renal insufficiency to receive either NaHCO 3 or NaCl and observed no difference in the CIN rates (14% each).
Ueda et al. [12] examined the benefit of rapid alkalinization with a bolus injection of either NaHCO 3 or NaCl immediately before emergency CAG in 59 patients with renal dysfunction and observed a significant reduction in CIN incidence in the NaHCO 3 group (3.3 vs 27.6%, P = 0.01).
Motohiro et al. [13] evaluated a 12-h pre-and post-procedure NaCl hydration regime with the intervention group being changed to NaHCO 3 3 h before till 6 h after contrast. The authors randomized 155 patients with underlying renal disease and demonstrated that a combination regime is more effective at reducing CIN rates than NaCl alone (13 vs 2.6%; P = 0.012).
Maioli et al. [14] investigated the effect of early preprocedural NaHCO 3 hydration, late NaCl hydration or no hydration in 450 patients undergoing emergency CAG after a ST-elevation myocardial infarction. Better CIN rates were found with early NaHCO 3 hydration (12 vs 22.7 vs 27.3%; P for trend = 0.001).
Klima et al.
[15] compared a 12-h pre-and post-procedure NaCl infusion with NaHCO 3 infusion 1 h before and 6 h after contrast in 258 patients with renal insufficiency and concluded that NaCl hydration is superior in preventing CIN (9 vs 1%, P = 0.02).
A recent meta-analysis by Jang et al. [16] incorporated 3609 patients across 19 trials and concluded that NaHCO 3 -based hydration regimes are superior to NaCl-based ones (odds ratio 0.56; 95% CI 0.36-0.86; P = 0.008). However, substantial heterogeneity (I 2 = 58%) due to variations in study protocol and publication bias may reduce the observed differences.
Gomes et al. [17] randomized 301 patients, with mild-to-moderate renal failure, to receive either NaHCO 3 or NaCl using the Merten et al. protocol and demonstrated similar CIN rates (6.1 vs 6.0%, P = 0.97), concluding that neither regimen is superior.
CLINICAL BOTTOM LINE
The need for adequate hydration to prevent CIN is well established. Several studies have demonstrated a clear benefit of urine alkalinization with NaHCO 3 . However, this should be taken in the context of substantial heterogeneity in study protocols. Based on this review, the authors recommend NaHCO 3 alongside an NaCl hydration regimen.
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